WA
The startup develops targeted radionuclide therapies that utilize radioactive drugs to treat various types of cancer. By providing precise and effective nuclear medicine solutions, the company enhances treatment options for patients and healthcare providers facing the challenges of cancer management.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted radionuclide therapies that utilize radioactive drugs to treat various types of cancer. By providing precise and effective nuclear medicine solutions, the company enhances treatment options for patients and healthcare providers facing the challenges of cancer management.